I-Mab Announces Accelerated Givastomig Phase 1b Study Progress

Go back to I-Mab Announces Accelerated Givastomig Phase 1b Study Progress
(NASDAQ: IMAB) Delayed: 4.63 --0 (-0%)
Previous Close $4.63    52 Week High
Open $4.63    52 Week Low
Day High $4.63    P/E N/A 
Day Low $4.63    EPS
Volume 3,500